NEWS

NanoSanguis S.A.’s cooperation agreement with A4BEE

We recently informed about the conclusion of an agreement on June 11 between NanoSanguis S.A. with A4BEE. Today we present more information about the cooperation we have already started. The purpose of the contract is to create a functional prototype to support the kidney perfusion process, and the implementation date was set by both parties for September 2024.

The NanOX project we are implementing is an original system consisting of a device and perfusion fluid for extracorporeal storage of organs intended for transplantation. During the implementation of the project, NanoSanguis S.A. on June 11, 2024, signed a cooperation agreement with A4BEE. A4BEE is a renowned partner with relevant market experience in the field of design and construction of advanced and groundbreaking technological solutions. The company supports international biotechnology, pharmaceutical and medical companies in developing and implementing innovative solutions. We hope that the established cooperation with such a dynamic and recognized partner will allow us to successfully certify the device.

The purpose of the concluded contract is to produce another, already 3rd, functional prototype to support the kidney perfusion process, as well as to transfer knowledge and prepare NanoSanguis S. A. to produce a production version of the device ready for certification. This is the next stage of the project’s development and at the same time another important step in the development of the NanOX Recovery Box device before the certification process. According to the contract, the deadline for completing the task was set for September 2024. The costs of this stage do not exceed PLN 500,000.

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.